Immunopathology of RSV: an updated review
HC Bergeron, RA Tripp - Viruses, 2021 - mdpi.com
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …
Interleukin‐17—A multifaceted cytokine in viral infections
U Sahu, D Biswas, VK Prajapati… - Journal of Cellular …, 2021 - Wiley Online Library
Viral infections are a major threat to the human population due to the lack of selective
therapeutic measures. The morbidity and mortality reported worldwide are very alarming …
therapeutic measures. The morbidity and mortality reported worldwide are very alarming …
[HTML][HTML] Sublingual vaccination and delivery systems
AL Paris, E Colomb, B Verrier, F Anjuère… - Journal of Controlled …, 2021 - Elsevier
Most infectious agents use mucosal tissues as entry portals, thus, mucosae are frequently
defined as a first line of defense against pathogens. Mucosal protection generally operates …
defined as a first line of defense against pathogens. Mucosal protection generally operates …
Current insights in the development of efficacious vaccines against RSV
JA Soto, LM Stephens, KA Waldstein… - Frontiers in …, 2020 - frontiersin.org
Inmunoterapia, Pontificia Universidad Católica de Chile, Santiago, Chile, 2 Interdisciplinary
Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States, 3 …
Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States, 3 …
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
HC Bergeron, J Murray, A Arora, AM Nuñez Castrejon… - Viruses, 2023 - mdpi.com
The respiratory syncytial virus (RSV) causes significant respiratory disease in young infants
and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti …
and the elderly. Immune prophylaxis in infants is currently limited to palivizumab, an anti …
IL-17A plays a critical role in RSV infection in children and mice
X Long, J Xie, L Ren, G Yu, E Liu, Y Deng, X Long - Virology Journal, 2023 - Springer
Background IL-17A is a pleiotropic cytokine and intimately associated with asthma, but its
role in respiratory syncytial virus (RSV) infection is conflicting in the literature. Methods …
role in respiratory syncytial virus (RSV) infection is conflicting in the literature. Methods …
Respiratory Syncytial Virus and Parainfluenza Virus: Characterizing Distinct Clinical Profiles and How They Shift with Bacterial Coinfection
B Nie, Y Cheng, H Hu - Journal of Pediatric Infectious Diseases, 2024 - thieme-connect.com
Objective The objectives are to characterize the distinct clinical profiles of respiratory
syncytial virus (RSV) and parainfluenza virus (PIV) infections and how these profiles shift …
syncytial virus (RSV) and parainfluenza virus (PIV) infections and how these profiles shift …
[引用][C] Estudio del efecto protector de la proteína recombinante SA-F3X-BBL utilizada como inmunógeno en ratones.
CB Barrón García - 2021 - Universidad Autónoma de …